Anika Therapeutics (ANIK) Return on Capital Employed Growth (3y) (2014 - 2026)
Anika Therapeutics (ANIK) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.88 Bn | 87.01 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 1,301.00 |
| 3 | Zoetis | 32.31 Bn | 30.37 Bn | 1.62 Bn | 331.00 |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -667.00 |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn | 480.00 |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn | -254.00 |
| 8 | Neurocrine Biosciences | 17.92 Bn | 16.61 Bn | 800.70 Mn | 1,342.00 |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | 1,902.00 |
| 10 | Anika Therapeutics | 205.13 Mn | 138.34 Mn | 19.00 Mn | -579.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -579.00 |
| Dec 31, 2025 | -773.00 |
| Sep 30, 2025 | -58.00 |
| Jun 30, 2025 | -71.00 |
| Mar 31, 2025 | -316.00 |
| Dec 31, 2024 | -345.00 |
| Sep 30, 2024 | 1,105.00 |
| Jun 30, 2024 | 1,017.00 |
| Mar 31, 2024 | 1,534.00 |
| Dec 31, 2023 | 831.00 |
| Sep 30, 2023 | -108.00 |
| Jun 30, 2023 | -547.00 |
| Mar 31, 2023 | -1,228.00 |
| Dec 31, 2022 | -994.00 |
| Sep 30, 2022 | -2,015.00 |
| Jun 30, 2022 | -1,710.00 |
| Mar 31, 2022 | -1,316.00 |
| Dec 31, 2021 | -746.00 |
| Sep 30, 2021 | -1,030.00 |
| Jun 30, 2021 | -1,373.00 |